United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin 5 mg in 1 ml - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hisun pharmaceuticals usa, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hisun pharmaceuticals usa, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hisun pharmaceuticals usa, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

halison pharmaceuiticals usa, inc - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin 20 mg in 4 ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - daunorubicin hydrochloride - powder for solution for infusion - 20mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - daunorubicin hydrochloride 2.14 mg/ml equivalent to daunorubicin 2 mg/ml - solution for injection - 2 mg/ml - active: daunorubicin hydrochloride 2.14 mg/ml equivalent to daunorubicin 2 mg/ml excipient: sodium chloride water for injection - daunorubicin injection is indicated for the treatment of the following: · acute lymphocytic (lymphoblastic) leukaemia: daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease.

Canada - English - Health Canada

teva canada limited - daunorubicin (daunorubicin hydrochloride) - powder for solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents

Canada - English - Health Canada

generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents